One post from Dr. Mindy Pelz's dossier. This page reviews a single piece of material. The full dossier carries the verified credential and scope verdicts.
Read the full dossier →https://web.archive.org/web/20260824150716/https://richroll.com/podcast/mindy-pelz-926/
View dossier →Mindy Pelz alias The Alzheimer’s Certainty Seller
Website · richroll.com#dean-sherzai
Practice location
11370 Anderson St Ste B-100
Loma Linda, CA 92354
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 15 health claims, 5 run counter to or conflict with the published evidence, and 6 were not independently checked.
- Primary persuasion tactic: Catastrophe-first Alzheimer’s framing.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend.
- Gives advice beyond what their license covers.
Dean Sherzai arrives with neurology credentials, a five-part lifestyle solution, and the confidence to make Alzheimer’s prevention sound like a completed engineering project. Add affiliate-linked books and sponsor/shop prompts, and the brain-health lecture starts looking suspiciously like a checkout page with citations in the lobby.
High grift signals
Score breakdown
Direct answer
Dr. Trust Me Bro analyzed Dr. Mindy Pelz's claim that "90% of all Alzheimer’s cases can be prevented." using transcript and metadata cross-checked against academic sources. Peer-reviewed literature indicates the claim is only partially supported: The claim is partly supported in that Alzheimer’s disease has no established pharmaceutical or surgical cure, and available treatments do not reverse established disease. Standard symptomatic drugs such as cholinesterase inhibitors and memantine can provide symptomatic relief or functional stabilization but do not eradicate the underlying pathology. [1] However, randomized trials and meta-analyses show that anti-amyloid monoclonal antibodies, including lecanemab and donanemab, can modestly slow cognitive and functional decline in selected people with early Alzheimer’s disease. Lecanemab reduced clinical decline over 18 months by about 27% versus placebo, and donanemab reduced decline in a phase 3 trial. Systematic-review evidence likewise reports significant but modest cognitive benefits from lecanemab, donanemab, and aducanumab, particularly in early-stage disease. The absolute statement that no pharmaceutical treatment can be effective is contradicted by randomized clinical-trial evidence and systematic reviews showing statistically significant slowing of decline with anti-amyloid therapies in early symptomatic Alzheimer’s disease. [2][3] The therapies do not reverse Alzheimer’s disease, prevent progression indefinitely, or restore lost cognition, and they carry important risks including amyloid-related imaging abnormalities and other adverse events. Evidence for prevention of Alzheimer’s disease in cognitively healthy people is not established, and there is no accepted surgical treatment that prevents or reverses typical Alzheimer’s disease. The supplied index papers are largely unrelated to Alzheimer’s disease; the traditional-board-games review addresses cognitive impairment prevention or slowing rather than pharmaceutical or surgical treatment and does not substantiate this claim. Alzheimer’s disease remains incurable, and no pharmaceutical or surgical intervention has been shown to reverse established disease or reliably prevent it in the general population. Nevertheless, saying that Western medicine has failed altogether is inaccurate: symptomatic medications offer limited benefits, and disease-modifying anti-amyloid antibodies are approved for carefully selected patients with early Alzheimer’s disease and modestly slow clinical decline, while requiring substantial monitoring and risk-benefit assessment. [4] The evidence supports slowing progression, not cure or reversal. Often searched as Dr Mindy Pelz.
Key findings
- Fear Mongering: The copy emphasizes death, devastation, hopelessness, and rising case counts before presenting the practice’s lifestyle program as the solution. That emotional sequence can make a strong prevention claim feel more credible than the evidence warrants.see section ↓
- Claim "Western medicine has failed to combat or cure Alzheimer’s, and no pharmaceutical or surgi…": only partially supported.see section ↓
- Claim "Lifestyle and nutrition constitute a comprehensive program to prevent Alzheimer’s disease…": not supported by peer-reviewed evidence.see section ↓
- Dr. Mindy Pelz shows credential inflation relative to stated vs likely credentials.see section ↓
- Against State Medical Board scope rules, these advertised activities appear outside Dr. Mindy Pelz's license (including conditions they merely list as ones they treat): 90% of all Alzheimer’s cases can be prevented., For people with strong genetic risk, Alzheimer’s can be delayed ten to fifteen…see section ↓
- 10 of 16 advertised activities assessed against board scope rules.see section ↓
- Claim "For people with strong genetic risk, Alzheimer’s can be delayed ten to fifteen years thro…": not supported by peer-reviewed evidence.see section ↓
- Claim "Food is the single greatest tool for fighting Alzheimer’s.": not supported by peer-reviewed evidence.see section ↓
Claims & evidence
8 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise 90% of all Alzheimer’s cases can be prevented. as within their scope of practice.
90% of all Alzheimer’s cases can be prevented.
- Supports
- A substantial proportion of dementia risk is associated with modifiable factors, including hypertension, diabetes, smoking, physical inactivity, obesity, and other cardiovascular risks. [9][10] A systematic review of systematic reviews estimated that about one-third of Alzheimer disease cases were attributable to five modifiable cardiovascular risk factors, although estimates varied by population and assumptions . [2][3][4][5][6][7][8][11][12] Reviews identify modifiable vascular and inflammatory processes as relevant contributors to Alzheimer disease risk, but they do not establish that most cases can be prevented . [1]
- Contradicts
- The claim that 90% of all Alzheimer’s cases can be prevented substantially exceeds available estimates. The 2024 Lancet Commission estimated that addressing 14 modifiable risk factors could potentially prevent about 45% of dementia cases globally, not 90%, and this is a population-attributable, theoretical estimate rather than proof that interventions will prevent that proportion . [2][9][10][11][12] Alzheimer disease has multiple interacting causes, including age-related, genetic, molecular, and neuropathological factors that are not currently preventable through established interventions . [1][3][4][6][7][8] The indexed reviews describe complex pathogenesis and uncertain translation from risk-factor associations to prevention, with no high-quality evidence demonstrating prevention of 90% of Alzheimer’s cases . [5]
- Mainstream view
- Risk reduction is worthwhile: controlling blood pressure, avoiding smoking, exercising, managing diabetes and cholesterol, treating hearing or vision loss, limiting excess alcohol, and maintaining social and cognitive engagement may reduce the risk of dementia. However, the best-supported estimates concern dementia overall and suggest that roughly 40% to 45% may be theoretically attributable to modifiable risk factors, with actual achievable prevention likely lower. [2][9][10][11][12] No major guideline or high-quality clinical evidence supports the statement that 90% of all Alzheimer’s cases can be prevented. Alzheimer disease prevention is therefore considered partial and probabilistic, not near-total. [1][3][4][5][6][7][8]
“90% of all Alzheimer’s cases can be prevented.”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise For people with strong genetic risk, Alzheimer’s can be delayed ten to fifteen years through the described approach. as within their scope of practice.
For people with strong genetic risk, Alzheimer’s can be delayed ten to fifteen years through the described approach.
- Supports
- Multidomain lifestyle interventions addressing exercise, diet, cognitive activity, and vascular risk factors can produce modest improvements or slower decline in cognition among older adults at increased dementia risk, including people with APOE4 genetic risk. [16][17][18][20] The 2020 Lancet Commission concluded that reducing modifiable risk factors might delay or prevent some dementia cases, including in people with genetic risk, although findings were not entirely consistent. [19] A systematic review of prevention trials found beneficial effects in a minority of trials, with FINGER providing evidence for cognitive benefit from a multidomain intervention, but most studies assessed cognition or intermediate outcomes rather than delayed Alzheimer disease onset. [13][14][21] The listed reviews describe synaptic, inflammatory, biomarker, and disease-modifying mechanisms relevant to Alzheimer disease, but they do not establish that any described approach delays disease onset by 10 to 15 years. [15]
- Contradicts
- No high-quality clinical evidence demonstrates that a specific approach delays Alzheimer disease by 10 to 15 years in people with strong genetic risk. Existing randomized trials generally lasted about 1 to 3 years and measured cognitive scores, biomarkers, or risk factors rather than a 10- to 15-year postponement of clinically diagnosed Alzheimer disease. [15][16][17][18][19][20] Evidence that lifestyle effects differ specifically between APOE4 carriers and noncarriers remains limited and inconclusive. A review of nutritional strategies states that no long-term human studies have established an effective prevention protocol for APOE4 carriers. [21] The index papers on synapse pathology, microglia-astrocyte communication, and Alzheimer pathophysiology are mechanistic or narrative reviews and do not provide direct evidence for the claimed duration of delay. [13][14]
- Mainstream view
- Healthy lifestyle and management of vascular, metabolic, sensory, educational, and social risk factors are recommended because they may reduce dementia risk or preserve cognitive function, including for people with genetic susceptibility. [16][17][18][19][20] However, genetic risk is not fully offset by lifestyle, and the magnitude and duration of any benefit are uncertain. A claim of delaying Alzheimer disease by 10 to 15 years for people with strong genetic risk is substantially more specific and stronger than the available evidence supports. [13][14][15][21]
“for the 10% with a strong genetic risk for cognitive decline, the disease can be delayed for ten to fifteen years.”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise Lifestyle and nutrition constitute a comprehensive program to prevent Alzheimer’s disease, improve cognition, and reverse symptoms. as within their scope of practice.
Lifestyle and nutrition constitute a comprehensive program to prevent Alzheimer’s disease, improve cognition, and reverse symptoms.
- Supports
- Lifestyle measures can reduce some modifiable dementia risks, and multidomain programs combining dietary counseling, exercise, cognitive training, and vascular-risk management have improved cognitive test performance in at-risk older adults in randomized trials. [23][24] The FINGER trial provides direct evidence for cognitive benefit, but it evaluated prevention of cognitive decline rather than reversal of Alzheimer’s disease . The 2024 Lancet Commission concluded that addressing 14 modifiable risk factors could potentially prevent or delay a substantial proportion of dementia cases, estimated at about 45% at the population level; this supports risk reduction, not guaranteed prevention in an individual . [9][22] A systematic review reports possible benefits from Mediterranean-style diets and selected nutritional interventions, particularly in mild-to-moderate Alzheimer’s disease, but emphasizes that more definitive research is needed . The indexed review of vascular risk-factor treatment also directly concerns whether such treatment prevents dementia and Alzheimer’s disease, supporting attention to vascular health as one component of prevention .
- Contradicts
- No high-quality evidence establishes that a lifestyle-and-nutrition program comprehensively prevents Alzheimer’s disease, improves cognition in all people, and reverses established Alzheimer’s symptoms. The FINGER evidence concerns selected older adults at elevated risk and a structured multidomain intervention; it does not demonstrate prevention of Alzheimer’s disease itself or reversal of established Alzheimer’s pathology . [9][23][24] Evidence for nutrition-specific interventions, including probiotics, ketones, supplements, and dietary patterns, remains heterogeneous and generally involves surrogate outcomes, small studies, mild cognitive impairment, or short follow-up rather than confirmed disease reversal . The indexed paper about positive maternal attitudes and lifestyle is observational or hypothesis-generating and cannot establish prevention or symptom reversal . The indexed systematic review of behavioral and psychological symptoms addresses caregiver burden and symptoms rather than proving that lifestyle or nutrition reverses Alzheimer’s disease .
- Mainstream view
- Healthy lifestyle practices—including regular physical activity, a balanced Mediterranean-style diet, control of hypertension, diabetes and cholesterol, avoidance of smoking and excessive alcohol, adequate sleep, hearing and vision care, and social and cognitive engagement—are recommended to reduce dementia risk and may help maintain cognitive function. [9][22][23][24] Multidomain interventions can produce modest improvements or slower decline in selected at-risk adults. However, Alzheimer’s disease is multifactorial, and lifestyle and nutrition are not considered a comprehensive or proven cure; they have not been shown to reliably reverse established Alzheimer’s disease symptoms or pathology. Claims of prevention should be framed as risk reduction or possible delay, not certainty.
“Team Sherzai’s 5-part program to prevent Alzheimer’s & reverse symptomology”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise Western medicine has failed to combat or cure Alzheimer’s, and no pharmaceutical or surgical treatment can effectively prevent or reverse it. as within their scope of practice.
Western medicine has failed to combat or cure Alzheimer’s, and no pharmaceutical or surgical treatment can effectively prevent or reverse it.
- Supports
- The claim is partly supported in that Alzheimer’s disease has no established pharmaceutical or surgical cure, and available treatments do not reverse established disease. [27] Standard symptomatic drugs such as cholinesterase inhibitors and memantine can provide symptomatic relief or functional stabilization but do not eradicate the underlying pathology. [25] However, randomized trials and meta-analyses show that anti-amyloid monoclonal antibodies, including lecanemab and donanemab, can modestly slow cognitive and functional decline in selected people with early Alzheimer’s disease. [26][28] Lecanemab reduced clinical decline over 18 months by about 27% versus placebo, and donanemab reduced decline in a phase 3 trial. Systematic-review evidence likewise reports significant but modest cognitive benefits from lecanemab, donanemab, and aducanumab, particularly in early-stage disease.
- Contradicts
- The absolute statement that no pharmaceutical treatment can be effective is contradicted by randomized clinical-trial evidence and systematic reviews showing statistically significant slowing of decline with anti-amyloid therapies in early symptomatic Alzheimer’s disease. [25][26][27][28] The therapies do not reverse Alzheimer’s disease, prevent progression indefinitely, or restore lost cognition, and they carry important risks including amyloid-related imaging abnormalities and other adverse events. Evidence for prevention of Alzheimer’s disease in cognitively healthy people is not established, and there is no accepted surgical treatment that prevents or reverses typical Alzheimer’s disease. The supplied index papers are largely unrelated to Alzheimer’s disease; the traditional-board-games review addresses cognitive impairment prevention or slowing rather than pharmaceutical or surgical treatment and does not substantiate this claim.
- Mainstream view
- Alzheimer’s disease remains incurable, and no pharmaceutical or surgical intervention has been shown to reverse established disease or reliably prevent it in the general population. [27] Nevertheless, saying that Western medicine has failed altogether is inaccurate: symptomatic medications offer limited benefits, and disease-modifying anti-amyloid antibodies are approved for carefully selected patients with early Alzheimer’s disease and modestly slow clinical decline, while requiring substantial monitoring and risk-benefit assessment. [25][26][28] The evidence supports slowing progression, not cure or reversal.
“The sad truth is that Alzheimer’s is a condition that Western medicine has utterly failed to combat, let alone cure. Simply put, there is no pharmaceutical or surgical treatment to effectively prevent or reverse this savage and cataclysmic condition.”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise Food is the single greatest tool for fighting Alzheimer’s. as within their scope of practice.
Food is the single greatest tool for fighting Alzheimer’s.
- Supports
- Healthy dietary patterns, particularly Mediterranean and MIND-style diets, are associated in observational studies with lower risks of cognitive impairment and Alzheimer’s disease. [30][31][32][33] A meta-analysis found higher Mediterranean-diet adherence associated with lower Alzheimer’s disease risk (RR 0. 89, 95% CI 0. 84–0. 93), although this evidence is mainly observational . Another systematic review found an approximately 29% lower Alzheimer’s disease risk with higher Mediterranean-diet adherence, but noted uncertainty in cognitive outcomes and limited randomized evidence . [29] A large cohort meta-analysis found approximately 17% lower incident dementia risk with highest versus lowest MIND-diet adherence .
- Contradicts
- The claim says food is the single greatest tool for fighting Alzheimer’s, which is substantially broader and stronger than the evidence supports. [32] The available index paper is a global disease-burden analysis and does not establish that food is the greatest intervention for Alzheimer’s disease . [29][31][33] The key randomized MIND-diet trial found no significant difference in three-year cognitive or brain-MRI outcomes versus a control diet with mild caloric restriction . [30] Reviews of nutritional interventions conclude that preliminary findings for nutrients and dietary counseling are insufficient to incorporate these interventions into clinical guidelines without larger, well-designed trials . Evidence for treating established Alzheimer’s disease is limited, heterogeneous, and does not show that food reverses or materially controls the disease; observational associations may also reflect overall health and lifestyle confounding.
- Mainstream view
- A healthy dietary pattern, especially Mediterranean- or MIND-style eating, is a reasonable component of dementia-risk reduction and general cardiovascular health, alongside physical activity, blood-pressure and diabetes control, smoking avoidance, adequate sleep, and social and cognitive engagement. [30][31][32] Food is not established as the single greatest tool, nor as a stand-alone treatment for established Alzheimer’s disease. [29][33] Current evidence supports potential modest preventive benefit, but causal effects and comparative superiority over other prevention strategies remain uncertain.
“Food is the single greatest tool we have in the fight against Alzheimer’s.”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise The practice markets nutrition and lifestyle changes as a way to prevent and reverse Alzheimer’s disease. as within their scope of practice.
The practice markets nutrition and lifestyle changes as a way to prevent and reverse Alzheimer’s disease.
- Supports
- Nutrition and lifestyle changes are recognized as potentially reducing dementia risk by addressing modifiable factors such as physical inactivity, hypertension, diabetes, obesity, smoking, excessive alcohol use, and high LDL cholesterol. [34][35][36][38][39][41][42] The 2024 Lancet Commission estimates that addressing 14 modifiable risk factors could potentially prevent or delay a substantial proportion of dementia cases, although this is a population-level estimate rather than proof that an individual intervention prevents Alzheimer’s disease. [43][10] A systematic review and meta-analysis identified evidence supporting several preventive behaviors, including physical exercise, weight management, smoking avoidance, adequate sleep, and management of vascular and metabolic risks. [44] The FINGER randomized trial found that a two-year multidomain intervention including dietary advice, exercise, cognitive training, and vascular-risk management improved cognitive performance in older adults at elevated dementia risk, but it did not establish prevention or reversal of Alzheimer’s disease itself. The supplied index papers are largely about nutrition and lifestyle in other conditions and do not directly support Alzheimer’s prevention or reversal. [37][40]
- Contradicts
- No high-quality evidence establishes that general nutrition and lifestyle changes reverse established Alzheimer’s disease. [34][35][36][38][39][41][42] A systematic review of lifestyle-based interventions in people with Alzheimer’s disease found that exercise may improve quality of life, while cognitive benefits were limited and modified diets, including ketogenic or Atkins-type diets, had inconsistent cognitive effects. [44] Evidence from multidomain prevention trials is heterogeneous: some trials report cognitive benefits, while others do not, and improvements in cognition are not equivalent to preventing Alzheimer’s disease or reversing its underlying pathology. [43][10] The available evidence therefore does not justify an unconditional marketing claim that nutrition and lifestyle changes prevent and reverse Alzheimer’s disease. [37][40]
- Mainstream view
- The mainstream medical view is that healthy diet, regular physical activity, management of cardiovascular and metabolic risk factors, avoidance of smoking and excessive alcohol, adequate sleep, and social or cognitive engagement are advisable and may reduce the risk of cognitive decline or dementia, particularly when begun before disease onset. [38][40][43][10] These measures are supportive risk-reduction strategies, not proven cures. Established Alzheimer’s disease cannot currently be reliably reversed through nutrition or lifestyle changes, and such measures should not replace evidence-based diagnosis, monitoring, or indicated medical treatment. [34][35][36][37][39][41][42][44]
“prevent Alzheimer’s disease, improve cognitive function, and ultimately optimize long-term brain health”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise The practice lists a program to reverse Alzheimer’s symptoms. as within their scope of practice.
The practice lists a program to reverse Alzheimer’s symptoms.
- Supports
- No high-quality evidence establishes that a general practice-based program reverses Alzheimer’s symptoms. [53][54][55][56] A small, nonrandomized ReCODE report described cognitive improvement or stabilization, but this is low-quality evidence and does not demonstrate reversal in a controlled trial. Current phase 3 studies of semaglutide are designed to evaluate efficacy and safety, so they do not yet establish symptom reversal. [45]
- Contradicts
- Established treatments are generally described as providing symptomatic relief, functional stabilization, or slowing of decline rather than reversing Alzheimer’s disease or its symptoms. [50][54][55][56] A systematic review of recent randomized trials found some possible cognitive benefits but emphasized the scarcity of evidence and need for further research, not demonstrated reversal. [49] Anti-amyloid therapies are intended for selected patients with early symptomatic disease and are used to slow decline; guidance requires biomarker confirmation and careful safety monitoring rather than presenting them as reversal programs. [45][47][53]
- Mainstream view
- The mainstream medical view is that Alzheimer’s disease has no proven program that reliably reverses symptoms. [50][54][55] Management combines accurate diagnosis, treatment of contributing conditions, symptomatic medications, cognitive and functional support, risk-factor management, and, for eligible patients with early amyloid-confirmed disease, disease-modifying anti-amyloid therapy that modestly slows decline. [45][47][52][53] Claims of reversal require confirmation in adequately powered randomized controlled trials with clinically meaningful outcomes.
“Team Sherzai’s 5-part program to prevent Alzheimer’s & reverse symptomology”
See every doc bro advertising Dementia and Alzheimer disease
Dr. Mindy Pelz is not licensed or approved by State Medical Board to advertise The Anti-Alzheimer’s Grocery List as within their scope of practice.
The Anti-Alzheimer’s Grocery List
No specific health claims of theirs were cross-checked against the literature.
“The Anti-Alzheimer’s Grocery List”
See every doc bro advertising Dementia and Alzheimer disease
Manipulation
transcript · cited
The copy emphasizes death, devastation, hopelessness, and rising case counts before presenting the practice’s lifestyle program as the solution. That emotional sequence can make a strong prevention claim feel more credible than the evidence warrants. Likely motive: Increase anxiety and receptivity to the branded program, books, and related commerce.
“This disease has become so pervasive, chances are you have been directly or indirectly impacted through an afflicted loved one.”
transcript · cited
The copy uses Dean Sherzai’s neurology training and research identity to give a high-certainty impression to population-level prevention and reversal claims that are not established clinical facts. Likely motive: Convert professional credentials into trust for books, programs, and the practice’s wider brand.
“These are not estimates. Nor are they wishful thinking. They are conclusions based on rigorous science performed by neurologists Drs. Dean and Ayesha Sherzai.”
transcript · cited
A complex and multifactorial disease is reduced to a precise, highly optimistic percentage without describing the study design, causal limitations, uncertainty, or distinction between risk reduction and prevention. Likely motive: Create a memorable headline that drives engagement and product or program interest.
“90% of all Alzheimer’s cases can be prevented.”
transcript · cited
A disclosure exists on the website, but the supplied content does not show an on-surface disclosure attached to each recommendation or the episode’s promotional language. The automated scan also found tracked Amazon links. Likely motive: Preserve the appearance of neutral recommendations while retaining commission income.
“Amazon Disclosure: Third-party books and products denoted on this page and website may be hyperlinked to the Amazon affiliate program.”
Commerce & grift map
The visible funnel is disease-threat content leading to books and sponsor/shop pathways, with Amazon tracking parameters creating potential commission income. No direct supplement-stack or lab-panel upsell is documented in the supplied material, so the strongest supported conflict is affiliate monetization of recommended books and products.
Amazon
Commerce
Amazon’s Associates program can pay a referral commission when readers click tracked links and buy qualifying products. Vendor page language: "Earn Commissions.Sign up Amazon Associates - Amazon’s affiliate marketing program Welcome to one of the largest affiliate marketing programs in the world."
Doc Bro outbound link (live) · Archive pending
Vendor provider compensation page (live) · Archive pending
Vendor language on provider benefit
- “Earn Commissions.Sign up Amazon Associates - Amazon’s affiliate marketing program Welcome to one of the largest affiliate marketing programs in the world.”
- “Earn Commissions.Sign up Operating agreement Program policies Conditions of use Contact us © 1996-2025, Amazon.com, Inc.”
How the money flows
- Affiliate / promo link The practice links to books and products through Amazon’s affiliate program, with tracked Amazon URLs detected for multiple titles. “We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed for us to earn fees by linking to Amazon.com and affiliated sites.”
“We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed for us to earn fees by linking to Amazon.com and affiliated sites.”
Store links detected
- Fast Like a Girl: A Woman’s Guide to Using the Healing Power of Fasting toHigh likelihood
“Amazon ref_ tracking parameter”
- The Menopause Reset: Get Rid of Your Symptoms and Feel Like Your Younger Self AgainHigh likelihood
“Amazon ref_ tracking parameter”
- The Alzheimer’s SolutionHigh likelihood
“Amazon tag parameter”
- The Book of JoyHigh likelihood
“Amazon tag parameter”
- Body WiseHigh likelihood
“Amazon tag parameter”
- Fast Like a Girl: A Woman’s Guide to Using the Healing Power of Fasting to Burn Fat, Boost Energy, and Balance HormonesHigh likelihood
“Amazon ref_ tracking parameter in URL”
- The Menopause Reset: Get Rid of Your Symptoms and Feel Like Your Younger Self AgainHigh likelihood
“Amazon ref_ tracking parameter in URL”
- Eat Like a Girl: 100+ Delicious Recipes to Balance Hormones, Boost Energy, and Burn FatHigh likelihood
“Affiliate program language on page”
Credentials & scope
Learn: Is a PhD a medical doctor?
Stated: M.D., PhD., two Masters Degrees, Masters in Public Health · Likely: MD, PhD, MPH, Master’s degrees in advanced sciences and public health
Dean Sherzai is presented as an MD physician with neurology residency training and fellowships in neurodegenerative disease, dementia, and geriatrics, plus doctoral and master’s degrees. The supplied material supports a real physician credential rather than an unverified borrowed title; concerns about broad prevention claims belong to evidence quality and conduct, not credential legitimacy.
Permitted scope vs advertised
State Medical Board · Confidence: low
The practice state is not provided, so the applicable state medical board and physician-practice statute cannot be identified or verified. An MD generally holds a broad license to diagnose and treat medical conditions, but specialty-specific standard-of-care assessment cannot be completed without the state and physician specialty.
10 of 16 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| 90% of all Alzheimer’s cases can be prevented. The definitive prevention percentage is contrary to the National Institute on Aging’s statement that no approach has been proven to prevent Alzheimer’s disease. | Outside scope |
| For people with strong genetic risk, Alzheimer’s can be delayed ten to fifteen years through the described approach. A definitive ten-to-fifteen-year delay claim exceeds the mainstream evidence, which describes lifestyle-prevention evidence as encouraging but inconclusive. | Outside scope |
| Lifestyle and nutrition constitute a comprehensive program to prevent Alzheimer’s disease, improve cognition, and reverse symptoms. Lifestyle and nutrition may support general cognitive health, but a comprehensive program claimed to prevent and reverse Alzheimer’s is not supported by the mainstream evidence base. | Outside scope |
| Western medicine has failed to combat or cure Alzheimer’s, and no pharmaceutical or surgical treatment can effectively prevent or reverse it. The categorical claim is medically misleading because it dismisses established symptomatic and disease-modifying care while overstating the limitations of medical treatment. | Outside scope |
| Food is the single greatest tool for fighting Alzheimer’s. NIA states that evidence for diets is mixed and that no specific food has been shown to prevent Alzheimer’s or cognitive decline, so this superlative is unsupported. | Outside scope |
| Listed service The practice markets nutrition and lifestyle changes as a way to prevent and reverse Alzheimer’s disease. Marketing nutrition and lifestyle as capable of reversing Alzheimer’s goes beyond evidence that supports only possible risk reduction or cognitive-health benefits. | Outside scope |
| Listed service The practice lists a program to reverse Alzheimer’s symptoms. A program advertised to reverse Alzheimer’s symptoms is a definitive therapeutic claim not established by the mainstream evidence base. | Outside scope |
| Listed service The Anti-Alzheimer’s Grocery List The title implies that selected foods can prevent Alzheimer’s, whereas NIA states that no specific food has been shown to do so. | Outside scope |
| Five-part program marketed to prevent Alzheimer’s and reverse symptoms The combined prevention-and-reversal promise is broader and more definitive than the available evidence, which remains encouraging but inconclusive for selected lifestyle interventions. | Outside scope |
| Nutrition and lifestyle program presented as a comprehensive Alzheimer’s solution Calling nutrition and lifestyle a comprehensive Alzheimer’s solution implies established prevention or treatment efficacy that mainstream evidence does not support. | Outside scope |
Sources: Preventing Alzheimer's Disease: What Do We Know? (official), What Do We Know About Diet and Prevention of Alzheimer's Disease? (official), Advanced Clinical Research in Lifestyle Interventions (official), Combination of healthy lifestyle traits may substantially reduce ... (official)
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Physician (MD/DO) scope permits near Loma Linda, CA. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-08-26 16:54 UTC. The archive pane loads styles and images from the intake snapshot.
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission 68qOlzSsXpbsldMW6P1l1
Fight disinformation
Log a public thread where Dr. Mindy Pelz is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Dr. Mindy Pelz's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/68qOlzSsXpbsldMW6P1l1. White-coat charisma isn't evidence.
Full DTMB scan on Dr. Mindy Pelz: https://drtrustmebro.com/analyze/68qOlzSsXpbsldMW6P1l1
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Dr. Mindy Pelz can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Dr. Mindy Pelz, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Dr. Mindy Pelz. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: va0fdpwIuFn4lLzQ_NPBy
- Wall entry: /influencer/va0fdpwIuFn4lLzQ_NPBy
- Analysis ID: 68qOlzSsXpbsldMW6P1l1
- Source: https://richroll.com/podcast/mindy-pelz-926?dtmb_roster=dean-sherzai
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review.
- [2] The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.
- [3] Pathogenesis of Alzheimer's Disease.
- [4] Cognitive Decline in Alzheimer's Disease.
- [5] Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier.
- [6] Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective.
- [7] Biomarkers for Alzheimer's Disease Diagnosis.
- [8] [Alzheimer’s disease – diagnosis and treatment].
- [9] Dementia prevention, intervention, and care 2024
- [10] Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
- [11] The potential for dementia prevention in Brazil: a population attributable fraction calculation for 14 modifiable risk factors
- [12] Population attributable fractions for modifiable risk factors of dementia in China: an updated analysis
- [13] Synapse pathology in Alzheimer's disease.
- [14] Microglia-Astrocyte Communication in Alzheimer's Disease.
- [15] Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs.
- [16] Effect of the ApoE genotype on the efficacy of multidomain lifestyle interventions on cognitive change: a meta‐analysis of three randomized clinical trials
- [17] Lifestyle, APOE‐e4, and cognitive performance: a systematic review
- [18] ɛ4 carriers with Subjective Cognitive Decline: a randomized, double ...
- [19] Life Course Modifiable Risk Factors for Dementia Stratified by ApoE ...
- [20] Prevention of cognitive decline in subjective cognitive decline APOE ε4 carriers after EGCG and a multimodal intervention (PENSA): Study design
- [21] Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers - PMC
- [22] Dementia: Almost half of cases could be prevented by tackling 14 risk factors, says commission
- [23] Subjective Memory Complaints and the Effect of a Multidomain Lifestyle Intervention on Cognition: The FINGER Trial - PubMed
- [24] GOIZ ZAINDU study: a FINGER-like multidomain lifestyle ...
- [25] Comparative efficacy and safety of symptomatic therapy ... - PMC
- [26] Systematic review and meta‐analysis of Alzheimer's disease clinical ...
- [27] A 2025 update on treatment strategies for the Alzheimer's ...
- [28] Do beta-amyloid-targeted interventions improve cognition, physical functioning, and overt behaviour of Alzheimer’s Disease (AD) patients: Protocol for meta-analysis of Phase 3 clinical trials both completed and terminated
- [29] Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- [30] Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons | NEJM
- [31] a systematic review and meta-analysis of observational studies
- [32] The Mediterranean-Dietary Approaches to Stop ...
- [33] Impact of Nutritional Interventions on Alzheimer's Disease
- [34] Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition.
- [35] Ovarian Cancer: Lifestyle, Diet and Nutrition.
- [36] Nutrition for Preconception Health and Fertility.
- [37] TFOS Lifestyle: Impact of nutrition on the ocular surface.
- [38] Diet, Nutrition, and Cancer Epigenetics.
- [39] Impact of Diet, Nutrition and Lifestyle on Reproductive Health.
- [40] Nutrition and Lifestyle Behaviours for the Prevention and Management of Multiple Sclerosis.
- [41] Nutrition and Health in Human Evolution-Past to Present.
- [42] Long‐term adherence to lifestyle changes and association ...
- [43] Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission
- [44] a systematic review of clinical trials combining multidomain lifestyle ...
- [45] evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.
- [46] A saturated map of common genetic variants associated with human height.
- [47] Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease.
- [48] A rapid review exploring nurse-led memory clinics.
- [49] Polygenic prediction of body mass index and obesity through the life course and across ancestries.
- [50] Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
- [51] Lewy body dementia: Overcoming barriers and identifying solutions.
- [52] A multifeature machine learning and resting-state EEG study reveals differences in beta oscillation in late-life depression with or without mild cognitive impairment.
- [53] Anti‐Amyloid Prescribing in Alzheimer's Disease: Ohio State ... - PMC
- [54] Evolving Alzheimer's Disease Clinical Practice - PubMed
- [55] The Alzheimer's Association clinical practice guideline ... - PMC
- [56] Are Appropriate Use Recommendations useful in clinical practice?